Skip to main content

Tweets

Baricitinib for *relapsing* GCA (Th1+Th17) w abbreviated steroid wean (15-22w) Despite being tougher to treat: 100% off steroids at 24w 93% off steroids at 52w no ischemic Sx promising as another GCA Rx option! (post-cessation 4pts flared) @MayoClinic #ACR21 ABST1396 @RheumNow https://t.co/dqFnHQYogk
David Liew @drdavidliew ( View Tweet )
4 years 8 months ago
It is #ACR21, but it is also #COP26Glasgow 🌎! What can we do for climate as physicians? "Our job is to make changes" Strong message for #ClimateAction from Dr Paul Dellaripa during his talk at the climate, pollution and IRMDs study group session @RheumNow https://t.co/GWxpzYD3lg
Aurelie Najm @AurelieRheumo ( View Tweet )
4 years 8 months ago
"GCA is not a single, monolithic disease" - Christian Dejaco, rightfully asking why we don't stratify treatment/trials in GCA #ACR21 PMR/GCA Study Group @RheumNow @Sarah_L_Mackie @profbdasgupta @EBRheum @RichardPAConway @SattuiSEMD @drceowen

David Liew @drdavidliew ( View Tweet )

4 years 8 months ago
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow and its Faculty.

Dr. John Cush @RheumNow ( View Tweet )

4 years 8 months ago
#ACR21 Abs#0819. RheumTAP real-world cohort of pts tapering Rx in remission on RA ▶️ Pts tapering 7.6x ⬆️ likely to flare in f/u Great convo soon on @Rheumnow re: tapering studies. @davidliew asks how many more times do we need to see drug w/d fail? https://t.co/BiZSM7yp7o https://t.co/iDXGVpFZzB
Eric Dein @ericdeinmd ( View Tweet )
4 years 8 months ago
#ACR21 Rheum Pearls and Secrets Not all (or most) ulcers is Behcet's! Here's a great approach to use in clinic. Jason Kolfenbach: "Sometimes, taking off the mask is worth it" @Rheumnow https://t.co/OEBgf1eFhd
Eric Dein @ericdeinmd ( View Tweet )
4 years 8 months ago
#ACR21. Powerful patient perspective by Amy Barron, RN and rheumatic patient ⭐️"I found hope advocating for arthritis" and found meaning in advocacy. ▶️ Consider talking to your patients about getting involved in ACR Advocacy to give purpose & community. @ACRheumDC @CreakyJoints https://t.co/2mJRaShZQQ
Eric Dein @ericdeinmd ( View Tweet )
4 years 8 months ago
Females axSpA pts presented w/ higher disease burden (fatigue/tiredness, & spinal pain at night.) Female axSpA pts achieved sign/symptom improvement with IXE later than male axSpA pts. Abs 0934 #ACR21 #RheumNow@RheumNow https://t.co/EGXnfeF6KQ https://t.co/TDF5zxtca7
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 8 months ago
Oral Calcitonin not recommended for OA - studies did not show efficacy Strontium Ranelate study below was considered a positive study in KOA with efficacy but had Cardiovascular toxicity - now off the market. https://t.co/gcYH9xoxeo
Bella Mehta @bella_mehta ( View Tweet )
4 years 8 months ago
Wnt signaling - Lorecivivint is now in phase 3 https://t.co/JSk2nPBTrI
Bella Mehta @bella_mehta ( View Tweet )
4 years 8 months ago
Abst 0789 Baker & colleagues examined adipokine levels in association with disease activity in RA patients - Patients with high levels of adipokines less likely to achieve low disease activity & remission - These patients more likely to escalate to b/tsDMARDs #ACR21 @RheumNow https://t.co/1xlO4W9q9v
Akhil Sood MD @AkhilSoodMD ( View Tweet )
4 years 8 months ago
Another exciting day at #ACR21 and covering for @RheumNow Also presented my poster (Abstr 0587) DMARD Use in Medicare Patients with #RheumatoidArthritis and Risk of Long-Term Opioid Use - DMARD users showed lower odds of long term opioid use compared to non-DMARD users https://t.co/2XZgYY8ORg
Akhil Sood MD @AkhilSoodMD ( View Tweet )
4 years 8 months ago
×